Metraipolis › archive › dc_7097474b0e2f
Outcomes of Patients With Autosomal Dominant Polycystic Kidney Disease Prescribed SGLT2 Inhibitors in British Columbia: A Single-Arm Retrospective Cohort Study — Europe PMC PMID:41393272
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41393272
- DOI
- 10.1177/20543581251404101
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T16:29:15.667Z
- SHA-256 of the archived text
90c6a939267e5e57c416a56f9a76d9abaa16de046aa97adcf2505b113032714d- Stable URL of this page
https://metraipolis.com/documento/dc_7097474b0e2f
How to cite
Outcomes of Patients With Autosomal Dominant Polycystic Kidney Disease Prescribed SGLT2 Inhibitors in British Columbia: A Single-Arm Retrospective Cohort Study — Europe PMC PMID:41393272 — Europe PMC (en), https://europepmc.org/article/MED/41393272 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7097474b0e2f (Metraipolis archive dc_7097474b0e2f, sha256 90c6a939267e5e57c416a56f9a76d9abaa16de046aa97adcf2505b113032714d)
BibTeX
@misc{dc7097474b0e2f,
title = {Outcomes of Patients With Autosomal Dominant Polycystic Kidney Disease Prescribed SGLT2 Inhibitors in British Columbia: A Single-Arm Retrospective Cohort Study — Europe PMC PMID:41393272},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41393272},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7097474b0e2f; sha256 90c6a939267e5e57c416a56f9a76d9abaa16de046aa97adcf2505b113032714d},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41393272. Agents can read the archived copy with the MCP tool read_document.